PRNewsWire
27 Jul 2026, 21:36 UTC · 12w ago
GeneDx Holdings Corp. (NASDAQ: WGS) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action
Impact · against what's priced in
GeneDx faces a significant legal and financial overhang following a securities class action lawsuit and a major impairment charge. The combination of a 49.2% stock price collapse, lowered 2026 guidance, and allegations of misleading investors regarding the Fabric Genomics acquisition creates a stark negative outlook for the company's near-term valuation.
- WGS−0.70
No priced-in read yet





